Analysis of Phosphatase Activity in a Droplet-Based Microfluidic Chip

Area of Science:

• Biochemistry
• Microfluidics
• Drug Discovery

Background:

• Phosphatases are crucial drug targets implicated in various diseases, including cancer, neurological disorders, diabetes, osteoporosis, and obesity.
• Existing methods for assessing phosphatase activity are often costly, require large sample volumes, and necessitate chemical modifications.

Purpose of the Study:

• To develop and validate a droplet-based microfluidic assay for analyzing phosphatase activity and inhibition.
• To evaluate the suitability of this platform for high-throughput screening of phosphatase inhibitors.

Main Methods:

• Utilized an artificial phosphatase substrate, 3-O-methylfluorescein phosphate, as a fluorescent reporter with dual specificity phosphatase 22.
• Performed phosphatase assays using approximately 340.4 picoliter droplets generated at ~40 Hz on a microfluidic chip.
• Conducted a dose-response inhibition study with ethyl-3,4-dephostatin to determine the half-maximal inhibitory concentration (IC50).

Main Results:

• Successfully performed phosphatase assays in picoliter droplets, demonstrating the feasibility of the droplet-based microfluidic approach.
• Calculated the IC50 for ethyl-3,4-dephostatin as 5.79 ± 1.09 μM, showing good agreement with microplate-based experiments.
• The droplet-based assay proved to be simple, reproducible, and capable of generating large datasets with minimal sample and reagent volumes.

Conclusions:

• The developed droplet-based microfluidic assay offers a simple, reproducible, and cost-effective method for analyzing phosphatase activity and inhibition.
• This platform is suitable for screening phosphatase inhibitors and has potential applications in drug discovery for phosphatase-related diseases.
• The assay's ability to handle limited sample volumes and generate extensive data makes it a valuable tool in biochemical research.